科学研究
学术论文
当前位置: 首页>>科学研究>>学术论文>>正文

    杨静等Hyaluronic acid and antimicrobial peptide-modified gold/silver hybrid nanocages to combat bacterial multidrug resistance

    2020-11-03   点击:[]

    Hyaluronic acid and antimicrobial peptide-modified gold/silver hybrid nanocages to combat bacterial multidrug resistance

    【作者】 Jing Yang, Yidan Zhao, Jian Cao, Changmei Gong, Jing Zuo, Nan Zhang, Yongxing Zhao

    【期刊名】 International Journal of Pharmaceutics

    【影响因子】 2019:4.845

    【作者单位】 Department of Pharmaceutics, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, Henan, PR China

    【年,卷():页码】2020, 586:119505

    【关键词】 Gold-silver hybrid nanocage,Antimicrobial peptides,Bacterial multidrug resistance,Photothermal therapy,Hyaluronic acid

    【摘要】Bacterial multidrug resistance is a major challenge for the treatment of infection. In this study, a gold-silver hybrid nanocage (Au/Ag NCs) is designed to conjugated with an antimicrobial peptide (AP) and hyaluronic acid (HA) via Au-S bond and electrostatic adsorption respectively. HA-P(Au/Ag) shows a small size (128 nm), a high efficiency of photothermal conversion, and a good stability. Under near-infrared (NIR) irradiation, HA-P(Au/Ag) effectively kills multidrug resistant bacteria-Acinetobacter baumannii (MDR-AB) by disrupting their inner and outer membrane. A pneumonia model caused by MDR-AB is established in mice. HA-P(Au/Ag) treatment reduces the number of bacterial colonies and inflammation in lung tissues and restores the structure of pulmonary alveoli. HA-P(Au/Ag)/NIR treatment increases the survival rate of pneumonia mice to 100%. Safety evaluation demonstrates that HA-P(Au/Ag) causes little cytotoxicity and hemolysis, and shows neglectable impact to the key indicators of kidney and liver function. To conclude, HA-P(Au/Ag) is a highly efficient and safe strategy that is promising to combat MDR-AB caused infection in vitro and in vivo.

    【全文链接】https://doi.org/10.1016/j.ijpharm.2020.119505


    上一条:陈润等Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes
    下一条:张楠等Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases

    关闭

版权所有:河南省靶向诊疗纳米药物重点实验室

地址:郑州市科学大道100号    邮编:450001